3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Osteosarcoma
1
Mouth Neoplasms
1
Interventions
Doxorubicin
5
Cyclophosphamide
4
anlotinib
3
Vincristine
3
Temozolomide
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Injections
3
polatuzumab vedotin
2
liposomal doxorubicin
2
glofitamab
2
envafolimab
2
X-Rays
2
Radiotherapy
2
Prednisone
2
Nivolumab
2
Neoadjuvant Therapy
2
Imatinib Mesylate
2
Biopsy
2
AZD 6244
2
toripalimab
1
surufatinib
1
spartalizumab
1
relmacabtagene autoleucel
1
regorafenib
1
penpulimab
1
pemigatinib
1
pazopanib
1
obinutuzumab
1
montelukast
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Positron Emission Tomography Computed Tomography
×
Sarcoma
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled